Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs116463976 | chr5:179484519 | G/C | 1.35E-5 | 176 | 24.23 | 32.15 | 25.17 | KM Plot |
PCPG | rs11646448 | chr16:89966357 | A/T | 0.000139 | 178 | 25.87 | 20.37 | 36.37 | KM Plot |
PCPG | rs11646697 | chr16:90132819 | C/A | 7.68E-9 | 177 | 25.87 | 20.13 | 6.62 | KM Plot |
PCPG | rs11646766 | chr16:89838578 | A/T | 0.000168 | 177 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs11646864 | chr16:85226819 | A/G | 1.76E-7 | 171 | 25.92 | 23.43 | 17.43 | KM Plot |
PCPG | rs11647027 | chr16:90074213 | A/C | 7.45E-9 | 177 | 25.77 | 20.37 | 6.62 | KM Plot |
PCPG | rs11647174 | chr16:89958538 | G/A | 0.000167 | 176 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs11648039 | chr16:90133581 | C/T | 8.72E-9 | 176 | 25.87 | 20.17 | 6.62 | KM Plot |
PCPG | rs11648433 | chr16:89965055 | G/A | 0.000167 | 175 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs11648552 | chr16:89891911 | T/G | 0.000198 | 172 | 26.22 | 20.28 | 36.37 | KM Plot |
PCPG | rs11648689 | chr16:89806732 | G/A | 0.000188 | 175 | 25.87 | 20.2 | 36.37 | KM Plot |
PCPG | rs11648818 | chr16:90049323 | G/A | 1.11E-8 | 172 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs11648879 | chr16:89827755 | A/G | 0.000193 | 175 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs11648881 | chr16:89862434 | T/C | 0.000179 | 174 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs11649100 | chr16:89798179 | A/G | 0.00018 | 175 | 25.87 | 20.28 | 36.37 | KM Plot |